欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3844/001
药品名称Influvac Tetra
活性成分
    • A/California/7/2009 (H1N1)pdm09-like virus 15.0 µg
    • A/Texas/50/2012 (H3N2) like virus 15.0 µg
    • B/Brisbane/60/2008 15.0 µg
    • B/Massachusetts/2/2012-like virus 15.0 µg
剂型SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
上市许可持有人Abbott Biologicals B.V. C.J. van Houtenlaan 36 Weesp the Netherlands
参考成员国 - 产品名称Netherlands (NL)
Influvac Tetra, suspensie voor injectie in voorgevulde spuit 0,5 ml
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Influvac Tetra, suspension injectable en seringue préremplie Vaccin contre la grippe (antigène de surface, inactivé) Saison 2014/2015
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Influvac Tetra Injektionssuspension in einer Fertigspritze
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Iceland (IS)
    • Hungary (HU)
      INFLUVAC TETRA szuszpenziós injekció előretöltött fecskendőben
    • Greece (GR)
      INFLUVAC SUB-UNIT TETRA®
    • Denmark (DK)
    • Sweden (SE)
    • Finland (FI)
    • Norway (NO)
      Influvac Tetra
    • Lithuania (LT)
      Influvac Tetra injekcinė suspensija užpildytame švirkšte
    • Poland (PL)
      Influvac Tetra
    • Latvia (LV)
      Influvac Tetra suspensija injekcijām pilnšļircē
    • Bulgaria (BG)
    • Estonia (EE)
      INFLUVAC TETRA
    • Cyprus (CY)
      Influvac® subunit Tetra, suspension for inj
    • Slovenia (SI)
    • Czechia (CZ)
      Influvac Tetra, injekční suspenze
    • Croatia (HR)
      Influvac Tetra, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv influence (površinski antigen), inaktivirano
    • Romania (RO)
    • Slovakia (SK)
      Influvac Tetra
    • Malta (MT)
      Influvac sub-unit Tetra, suspension for injection
许可日期2017/07/10
最近更新日期2025/02/10
药物ATC编码
    • J07BB02 influenza, inactivated, split virus or surface antigen
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Biological: Vaccine
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase